Pharmaceutical Institute, Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo n. 2, 16610, Prague, Czech Republic.
Chemistry. 2022 Nov 7;28(62):e202201636. doi: 10.1002/chem.202201636. Epub 2022 Sep 7.
Rhodesain is the major cysteine protease of the protozoan parasite Trypanosoma brucei and a therapeutic target for sleeping sickness, a fatal neglected tropical disease. We designed, synthesized and characterized a bimodal activity-based probe that binds to and inactivates rhodesain. This probe exhibited an irreversible mode of action and extraordinary potency for the target protease with a k /K value of 37,000 M s . Two reporter tags, a fluorescent coumarin moiety and a biotin affinity label, were incorporated into the probe and enabled highly sensitive detection of rhodesain in a complex proteome by in-gel fluorescence and on-blot chemiluminescence. Furthermore, the probe was employed for microseparation and quantification of rhodesain and for inhibitor screening using a competition assay. The developed bimodal rhodesain probe represents a new proteomic tool for studying Trypanosoma pathobiochemistry and antitrypanosomal drug discovery.
罗得西亚素是原生动物寄生虫布氏锥虫的主要半胱氨酸蛋白酶,也是昏睡病(一种致命的被忽视热带病)的治疗靶点。我们设计、合成并表征了一种双模态的基于活性的探针,该探针可与罗得西亚素结合并使其失活。该探针对靶蛋白酶表现出不可逆的作用模式和非凡的效力,其 k /K 值为 37,000 M s 。两个报告标签,荧光香豆素部分和生物素亲和标记,被掺入探针中,并通过胶内荧光和印迹化学发光实现了复杂蛋白质组中罗得西亚素的高灵敏度检测。此外,该探针还用于微分离和定量罗得西亚素,并使用竞争测定法进行抑制剂筛选。开发的双模态罗得西亚素探针代表了一种研究锥虫病理生物化学和抗锥虫药物发现的新蛋白质组学工具。